Cambridge, MASS., May 29, 2019 – Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present a company overview at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 9:30 a.m. ET. The conference is being held June 4-7, 2019 in New York City.
About Beam Therapeutics
Beam Therapeutics is developing precision genetic medicines through base editing, a next-generation gene editing technology. Founded by leading scientists in gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single bases (A, G, C, T) in DNA and RNA. Beam is headquartered in Cambridge, Mass. For additional information, visit www.BeamTx.com.
THRUST Strategic Communications